Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER plus Advanced Breast Cancer

导出原文传递

翻译打印收藏纠错

作者： O'Leary, Ben ^[1] ; Cutts, Rosalind J. ^[2] ; Huang, Xin ^[3] ; Hrebien, Sarah ^[4] ; Liu, Yuan ^[5] ; Andre, Fabrice ^[6] ; Loibl, Sibylle ; Loi, Sherene ; Garcia-Murillas, Isaac ; Cristofanilli, Massimo ; Bartlett, Cynthia Huang ; Turner, Nicholas C.

作者单位： Univ Paris Sud, Inst Gustave Roussy, Dept Med Oncol, Villejuif, France ^[1] German Breast Grp, Martin Behaim Str 12, Neu Isenburg, Germany ^[2] Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA ^[3] Univ Melbourne, Peter MacCallum Canc Ctr, Div Res & Canc Med, Melbourne, Vic, Australia ^[4] Pfizer, New York, NY USA ^[5] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England ^[6]

发布时间 2021-06-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of the National Cancer Institute

2021年113卷3期

309-317页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER plus Advanced Breast Cancer

Journal of the National Cancer Institute

相似文献

Journal of the National Cancer Institute

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER plus Advanced Breast Cancer

Journal of the National Cancer Institute

相似文献

Journal of the National Cancer Institute

相关期刊

检索历史清除